Pruritus Therapeutics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Pruritus Therapeutics Market
1.1. Definition and Scope
1.1.1. Definition of Pruritus Therapeutics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pruritus Therapeutics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pruritus Therapeutics Market By Disease Type
1.2.3. Pruritus Therapeutics Market By Product
1.2.4. Pruritus Therapeutics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pruritus Therapeutics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pruritus Therapeutics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Pruritus Therapeutics Market By Disease Type
5.1. Introduction
5.2. Pruritus Therapeutics Revenue By Disease Type
5.2.1. Pruritus Therapeutics Revenue (USD Billion) and Forecast, By Disease Type, 2020-2032
5.2.2. Atopic Dermatitis
5.2.2.1. Atopic Dermatitis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Urticaria
5.2.3.1. Urticaria Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Allergic Contact Dermatitis
5.2.4.1. Allergic Contact Dermatitis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Others
5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Pruritus Therapeutics Market By Product
6.1. Introduction
6.2. Pruritus Therapeutics Revenue By Product
6.2.1. Pruritus Therapeutics Revenue (USD Billion) and Forecast, By Product, 2020-2032
6.2.2. Corticosteroids
6.2.2.1. Corticosteroids Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Local Anesthetics
6.2.3.1. Local Anesthetics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Antihistamines
6.2.4.1. Antihistamines Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Counterirritants
6.2.5.1. Counterirritants Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Calcineurin Inhibitors
6.2.6.1. Calcineurin Inhibitors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.7. Immunosuppressant
6.2.7.1. Immunosuppressant Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.8. Others
6.2.8.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Pruritus Therapeutics Market By Country
7.1. North America Pruritus Therapeutics Market Overview
7.2. U.S.
7.2.1. U.S. Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
7.2.2. U.S. Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
7.3. Canada
7.3.1. Canada Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
7.3.2. Canada Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Pruritus Therapeutics Market By Country
8.1. Europe Pruritus Therapeutics Market Overview
8.2. U.K.
8.2.1. U.K. Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
8.2.2. U.K. Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
8.3. Germany
8.3.1. Germany Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
8.3.2. Germany Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
8.4. France
8.4.1. France Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
8.4.2. France Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
8.5. Spain
8.5.1. Spain Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
8.5.2. Spain Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
8.6.2. Rest of Europe Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Pruritus Therapeutics Market By Country
9.1. Asia Pacific Pruritus Therapeutics Market Overview
9.2. China
9.2.1. China Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
9.2.2. China Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3. Japan
9.3.1. Japan Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
9.3.2. Japan Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
9.4. India
9.4.1. India Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
9.4.2. India Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
9.5. Australia
9.5.1. Australia Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
9.5.2. Australia Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
9.6. South Korea
9.6.1. South Korea Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
9.6.2. South Korea Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
9.7.2. Rest of Asia-Pacific Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Pruritus Therapeutics Market By Country
10.1. Latin America Pruritus Therapeutics Market Overview
10.2. Brazil
10.2.1. Brazil Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
10.2.2. Brazil Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3. Mexico
10.3.1. Mexico Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
10.3.2. Mexico Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
10.4.2. Rest of Latin America Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Pruritus Therapeutics Market By Country
11.1. Middle East & Africa Pruritus Therapeutics Market Overview
11.2. GCC
11.2.1. GCC Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
11.2.2. GCC Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3. South Africa
11.3.1. South Africa Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
11.3.2. South Africa Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Pruritus Therapeutics Revenue (USD Billion) and Forecast By Disease Type, 2020-2032
11.4.2. Rest of Middle East & Africa Pruritus Therapeutics Revenue (USD Billion) and Forecast By Product, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Pruritus Therapeutics Market
12.1. Pruritus Therapeutics Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Pruritus Therapeutics Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 13. Company Profile
13.1. Novartis AG
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2022
13.1.3.2. Novartis AG 2022 Pruritus Therapeutics Business Regional Distribution
13.1.4. Product/Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Pfizer Inc.
13.3. Sanofi S.A.
13.4. GlaxoSmithKline plc
13.5. Johnson & Johnson
13.6. Merck & Co., Inc.
13.7. Eli Lilly and Company
13.8. Teva Pharmaceutical Industries Ltd.
13.9. AstraZeneca plc
13.10. AbbVie Inc.
13.11. Bayer AG
13.12. Allergan plc
Frequently Asked Questions
What was the market size of the global pruritus therapeutics in 2022?
The market size of pruritus therapeutics was USD 8.4 Billion in 2022.
What is the CAGR of the global pruritus therapeutics market from 2023 to 2032?
The CAGR of pruritus therapeutics is 3.9% during the analysis period of 2023 to 2032.
Which are the key players in the pruritus therapeutics market?
The key players operating in the global market are including Novartis AG, Pfizer Inc., Sanofi S.A., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, AbbVie Inc., Bayer AG, and Allergan plc.
Which region dominated the global pruritus therapeutics market share?
North America held the dominating position in pruritus therapeutics industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of pruritus therapeutics during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global pruritus therapeutics industry?
The current trends and dynamics in the pruritus therapeutics market growth include increasing prevalence of chronic skin conditions and systemic diseases, and advancements in pharmaceutical R&D leading to innovative therapies.
Which disease type held the maximum share in 2022?
The atopic dermatitis disease type held the maximum share of the pruritus therapeutics industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
